1h Free Analyst Time
The global bronchitis treatment market is forecasted to grow by USD 802.8 million during 2025-2030, accelerating at a CAGR of 3.3% during the forecast period. The report on the global bronchitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising chronic respiratory conditions and environmental degradation, innovations in pharmaceutical formulations and targeted delivery mechanisms, strengthening of global healthcare frameworks and favorable regulatory policies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global bronchitis treatment market is segmented as below:
By Drug Class
- Antibiotics
- Anti inflammatory drugs
- Bronchodilator
By Type
- Acute bronchitis
- Chronic bronchitis
By Route Of Administration
- Oral
- Parenteral
- Inhalation
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global bronchitis treatment market covers the following areas:
- Global bronchitis treatment market sizing
- Global bronchitis treatment market forecast
- Global bronchitis treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Bronchitis Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Bronchitis Treatment Market 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Bronchitis Treatment Market
6.2 Impact of Geopolitical Conflict on Global Bronchitis Treatment Market
6.2 Impact of Geopolitical Conflict on Global Bronchitis Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Drug Class
8.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Antibiotics - Market size and forecast 2025-2030 ($ million)
- Data Table on Antibiotics - Market size and forecast 2025-2030 ($ million)
- Chart on Antibiotics - Year-over-year growth 2025-2030 (%)
- Data Table on Antibiotics - Year-over-year growth 2025-2030 (%)
- Chart on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
- Chart on Bronchodilator - Market size and forecast 2025-2030 ($ million)
- Data Table on Bronchodilator - Market size and forecast 2025-2030 ($ million)
- Chart on Bronchodilator - Year-over-year growth 2025-2030 (%)
- Data Table on Bronchodilator - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Type
9.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
- Data Table on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
- Chart on Acute bronchitis - Year-over-year growth 2025-2030 (%)
- Data Table on Acute bronchitis - Year-over-year growth 2025-2030 (%)
- Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
- Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
- Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
- Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Parenteral - Market size and forecast 2025-2030 ($ million)
- Data Table on Parenteral - Market size and forecast 2025-2030 ($ million)
- Chart on Parenteral - Year-over-year growth 2025-2030 (%)
- Data Table on Parenteral - Year-over-year growth 2025-2030 (%)
- Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
- Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
- Chart on Inhalation - Year-over-year growth 2025-2030 (%)
- Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising chronic respiratory conditions and environmental degradation
- Innovations in pharmaceutical formulations and targeted delivery mechanisms
- Strengthening of global healthcare frameworks and favorable regulatory policies
- High costs of advanced therapeutics and inequitable market access
- Stringent regulatory hurdles and complexity of drug approval processes
- Emergence of antibiotic resistance and shifting clinical guidelines
- Impact of drivers and challenges in 2025 and 2030
- Emergence of precision medicine and biologic interventions
- Integration of digital health and smart respiratory management systems
- Emphasis on pulmonary rehabilitation and integrated care models
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key news
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Mankind Pharma Ltd. - Overview
- Mankind Pharma Ltd. - Business segments
- Mankind Pharma Ltd. - Key news
- Mankind Pharma Ltd. - Key offerings
- Mankind Pharma Ltd. - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Torrent Pharmaceuticals Ltd. - Overview
- Torrent Pharmaceuticals Ltd. - Product / Service
- Torrent Pharmaceuticals Ltd. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Bronchitis Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 39: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Drug Class
Exhibit 41: Data Table on Comparison by Drug Class
Exhibit 42: Chart on Antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Bronchodilator - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Bronchodilator - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Bronchodilator - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Bronchodilator - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Drug Class ($ million)
Exhibit 55: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 56: Chart on Type - Market share 2025-2030 (%)
Exhibit 57: Data Table on Type - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
Exhibit 60: Chart on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Acute bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Acute bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
Exhibit 70: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 71: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Route of Administration
Exhibit 73: Data Table on Comparison by Route of Administration
Exhibit 74: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Parenteral - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Parenteral - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Parenteral - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Parenteral - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Route of Administration ($ million)
Exhibit 87: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Abbott Laboratories - Overview
Exhibit 219: Abbott Laboratories - Business segments
Exhibit 220: Abbott Laboratories - Key news
Exhibit 221: Abbott Laboratories - Key offerings
Exhibit 222: Abbott Laboratories - Segment focus
Exhibit 223: SWOT
Exhibit 224: Astellas Pharma Inc. - Overview
Exhibit 225: Astellas Pharma Inc. - Product / Service
Exhibit 226: Astellas Pharma Inc. - Key news
Exhibit 227: Astellas Pharma Inc. - Key offerings
Exhibit 228: SWOT
Exhibit 229: AstraZeneca Plc - Overview
Exhibit 230: AstraZeneca Plc - Business segments
Exhibit 231: AstraZeneca Plc - Key news
Exhibit 232: AstraZeneca Plc - Key offerings
Exhibit 233: AstraZeneca Plc - Segment focus
Exhibit 234: SWOT
Exhibit 235: Cipla Inc. - Overview
Exhibit 236: Cipla Inc. - Business segments
Exhibit 237: Cipla Inc. - Key news
Exhibit 238: Cipla Inc. - Key offerings
Exhibit 239: Cipla Inc. - Segment focus
Exhibit 240: SWOT
Exhibit 241: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 242: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 243: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 244: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 245: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 246: SWOT
Exhibit 247: F. Hoffmann La Roche Ltd. - Overview
Exhibit 248: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 249: F. Hoffmann La Roche Ltd. - Key news
Exhibit 250: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 251: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 260: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 261: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 262: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 263: SWOT
Exhibit 264: Mankind Pharma Ltd. - Overview
Exhibit 265: Mankind Pharma Ltd. - Business segments
Exhibit 266: Mankind Pharma Ltd. - Key news
Exhibit 267: Mankind Pharma Ltd. - Key offerings
Exhibit 268: Mankind Pharma Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Merck and Co. Inc. - Overview
Exhibit 271: Merck and Co. Inc. - Business segments
Exhibit 272: Merck and Co. Inc. - Key news
Exhibit 273: Merck and Co. Inc. - Key offerings
Exhibit 274: Merck and Co. Inc. - Segment focus
Exhibit 275: SWOT
Exhibit 276: Novartis AG - Overview
Exhibit 277: Novartis AG - Business segments
Exhibit 278: Novartis AG - Key news
Exhibit 279: Novartis AG - Key offerings
Exhibit 280: Novartis AG - Segment focus
Exhibit 281: SWOT
Exhibit 282: Pfizer Inc. - Overview
Exhibit 283: Pfizer Inc. - Business segments
Exhibit 284: Pfizer Inc. - Key news
Exhibit 285: Pfizer Inc. - Key offerings
Exhibit 286: Pfizer Inc. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Sanofi SA - Overview
Exhibit 289: Sanofi SA - Business segments
Exhibit 290: Sanofi SA - Key news
Exhibit 291: Sanofi SA - Key offerings
Exhibit 292: Sanofi SA - Segment focus
Exhibit 293: SWOT
Exhibit 294: Teva Pharmaceutical Ltd. - Overview
Exhibit 295: Teva Pharmaceutical Ltd. - Business segments
Exhibit 296: Teva Pharmaceutical Ltd. - Key news
Exhibit 297: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 298: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 301: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 302: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Bronchitis Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 39: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Drug Class
Exhibit 41: Data Table on Comparison by Drug Class
Exhibit 42: Chart on Antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Anti inflammatory drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Anti inflammatory drugs - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Bronchodilator - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Bronchodilator - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Bronchodilator - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Bronchodilator - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Drug Class ($ million)
Exhibit 55: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 56: Chart on Type - Market share 2025-2030 (%)
Exhibit 57: Data Table on Type - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
Exhibit 60: Chart on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Acute bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Acute bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Acute bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
Exhibit 70: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 71: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Route of Administration
Exhibit 73: Data Table on Comparison by Route of Administration
Exhibit 74: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Parenteral - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Parenteral - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Parenteral - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Parenteral - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Route of Administration ($ million)
Exhibit 87: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Abbott Laboratories - Overview
Exhibit 219: Abbott Laboratories - Business segments
Exhibit 220: Abbott Laboratories - Key news
Exhibit 221: Abbott Laboratories - Key offerings
Exhibit 222: Abbott Laboratories - Segment focus
Exhibit 223: SWOT
Exhibit 224: Astellas Pharma Inc. - Overview
Exhibit 225: Astellas Pharma Inc. - Product / Service
Exhibit 226: Astellas Pharma Inc. - Key news
Exhibit 227: Astellas Pharma Inc. - Key offerings
Exhibit 228: SWOT
Exhibit 229: AstraZeneca Plc - Overview
Exhibit 230: AstraZeneca Plc - Business segments
Exhibit 231: AstraZeneca Plc - Key news
Exhibit 232: AstraZeneca Plc - Key offerings
Exhibit 233: AstraZeneca Plc - Segment focus
Exhibit 234: SWOT
Exhibit 235: Cipla Inc. - Overview
Exhibit 236: Cipla Inc. - Business segments
Exhibit 237: Cipla Inc. - Key news
Exhibit 238: Cipla Inc. - Key offerings
Exhibit 239: Cipla Inc. - Segment focus
Exhibit 240: SWOT
Exhibit 241: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 242: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 243: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 244: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 245: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 246: SWOT
Exhibit 247: F. Hoffmann La Roche Ltd. - Overview
Exhibit 248: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 249: F. Hoffmann La Roche Ltd. - Key news
Exhibit 250: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 251: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 260: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 261: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 262: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 263: SWOT
Exhibit 264: Mankind Pharma Ltd. - Overview
Exhibit 265: Mankind Pharma Ltd. - Business segments
Exhibit 266: Mankind Pharma Ltd. - Key news
Exhibit 267: Mankind Pharma Ltd. - Key offerings
Exhibit 268: Mankind Pharma Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Merck and Co. Inc. - Overview
Exhibit 271: Merck and Co. Inc. - Business segments
Exhibit 272: Merck and Co. Inc. - Key news
Exhibit 273: Merck and Co. Inc. - Key offerings
Exhibit 274: Merck and Co. Inc. - Segment focus
Exhibit 275: SWOT
Exhibit 276: Novartis AG - Overview
Exhibit 277: Novartis AG - Business segments
Exhibit 278: Novartis AG - Key news
Exhibit 279: Novartis AG - Key offerings
Exhibit 280: Novartis AG - Segment focus
Exhibit 281: SWOT
Exhibit 282: Pfizer Inc. - Overview
Exhibit 283: Pfizer Inc. - Business segments
Exhibit 284: Pfizer Inc. - Key news
Exhibit 285: Pfizer Inc. - Key offerings
Exhibit 286: Pfizer Inc. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Sanofi SA - Overview
Exhibit 289: Sanofi SA - Business segments
Exhibit 290: Sanofi SA - Key news
Exhibit 291: Sanofi SA - Key offerings
Exhibit 292: Sanofi SA - Segment focus
Exhibit 293: SWOT
Exhibit 294: Teva Pharmaceutical Ltd. - Overview
Exhibit 295: Teva Pharmaceutical Ltd. - Business segments
Exhibit 296: Teva Pharmaceutical Ltd. - Key news
Exhibit 297: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 298: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 301: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 302: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global bronchitis treatment market: Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., Cipla Inc., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Lupin Ltd., Mankind Pharma Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Torrent Pharmaceuticals Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of precision medicine and biologic interventions."
According to the report, one of the major drivers for this market is the rising chronic respiratory conditions and environmental degradation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Astellas Pharma Inc.
- AstraZeneca Plc
- Boehringer Ingelheim GmbH
- Chiesi Farmaceutici S.p.A.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Mankind Pharma Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- Torrent Pharmaceuticals Ltd.
